NED TALK 2021: Navigating the Increasingly Complex Therapeutic Landscape in Contemporary Myeloma Care

Download All
Download teaching slidesets and listen to audio podcasts from our live, virtual Nursing Education Day (“NED Talks”!) on multiple myeloma. These 4 talks by expert nurses were designed to spark conversation on navigating the therapeutic landscape to improve outcomes for patients with multiple myeloma.
Donna Catamero, ANP-BC, OCN, CCRC
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Charise Gleason, MSN, NP-BC, AOCNP
Tiffany Richards, PhD, ANP-BC, AOCNP

Podcasts

In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, shares clinical considerations, from a nursing perspective, on diagnosis and optimal treatment for personalizing management of newly diagnosed multiple myeloma.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 14, 2021 Expired: No longer available for credit

In this podcast episode, Charise Gleason, MSN, NP-BC, AOCNP, discusses her perspective on key considerations when caring for patients with myeloma after relapse on initial therapy.

Charise Gleason, MSN, NP-BC, AOCNP Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 14, 2021 Expired: No longer available for credit

In this podcast episode, Tiffany Richards, PhD, ANP-BC, AOCNP, discusses the key data and nursing considerations for integrating novel classes of agents into the treatment plan for R/R MM, with a focus on combinations with selinexor, venetoclax and melphalan flufenamide.

Tiffany Richards, PhD, ANP-BC, AOCNP Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 16, 2021 Expired: No longer available for credit

In this podcast episode, Donna Catamero, ANP-BC, OCN, CCRC, highlights the key data and nursing considerations for integrating BCMA-targeted agents into the treatment plan for R/R MM, with a focus on belantamab mafodotin and idecabtagene vicleucel.

Donna Catamero, ANP-BC, OCN, CCRC Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 19, 2021 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Oncopeptides
Sanofi Genzyme Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings